Cooley advised Kriya Therapeutics on the deal. Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing […]
Kriya Therapeutics’ $270 Million Series C Financing Round
Lacework’s $1.3 Billion Series D Financing Round
Cooley advised Lacework on the deal. Lacework, a data-driven security platform for the cloud, announced its $1.3 billion Series D financing round, which brings its valuation to […]
Lyell Immunopharma’s $425 Million Initial Pubic Offering
Latham & Watkins Advises the Underwriters in the offering while Cooley LLP represented Lyell Immunopharma. Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company […]
Mollie’s Series C Investment Round
NautaDutilh and Weil, Gotshal & Manges advised Blackstone Growth on the deal and De Brauw has advised Mollie. Freshfields Bruckhaus Deringer advised EQT Growth. Kennedy Van […]